Valuation: GC Genome Corporation

Market Cap 193B 142M 124M 117M 107M 200M 13.58B 202M 1.4B 545M 6.92B 531M 520M 22.53B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 134M 98.13K 86.2K 81.24K 74.27K 139K 9.41M 140K 974K 378K 4.79M 368K 360K 15.61M EV / Sales 2026 *
3.44x
EV / Sales 2027 * 2.55x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day+12.21%
1 week+21.55%
Current month+38.18%
1 month+51.76%
3 months+82.18%
6 months+10.54%
Current year+19.94%
1 week 6,580
Extreme 6580
8,350
1 month 5,120
Extreme 5120
8,350
Current year 4,100
Extreme 4100
9,520
1 year 4,100
Extreme 4100
9,520
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 2020-03-25
Director of Finance/CFO 50 2025-03-26
Comptroller/Controller/Auditor 45 2024-03-28
Director TitleAgeSince
Director/Board Member 57 2023-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/17/25 Free

Chief Executive Officer

169,285 -
6/17/25 Free 138,250 --
Change 5-day change 1-year change 3-year change Capi.($)
+12.21%+21.55%+0.99% - 142M
+4.61%+18.37%+136.53%+792.16% 56.33B
+1.63%-4.79%+10.36%+50.60% 24.65B
-0.53%-3.22%-14.36%-38.20% 6.62B
-2.60%-5.90%-7.68%+158.28% 5.76B
+1.92%+3.46%+17.79%+67.66% 3.36B
+3.85%-9.18%-27.16%+2,364.62% 2.54B
+6.54%+3.27%+140.59%+60.99% 2.36B
+17.77%+2.56%+35.30%+45.12% 2.32B
+1.10%+8.21%+0.72%-52.89% 1.98B
Average +4.65%+1.14%+29.31%+383.15% 10.61B
Weighted average by Cap. +3.38%+5.02%+77.44%+499.53%

Financials

2026 *2027 *
Net sales 39B 28.55M 25.08M 23.63M 21.61M 40.33M 2.74B 40.68M 283M 110M 1.39B 107M 105M 4.54B 48.8B 35.72M 31.38M 29.57M 27.04M 50.46M 3.43B 50.9M 354M 138M 1.74B 134M 131M 5.68B
Net income - -
Net Debt -59.4B -43.48M -38.19M -36M -32.91M -61.42M -4.17B -61.95M -431M -167M -2.12B -163M -160M -6.92B -68.8B -50.36M -44.24M -41.69M -38.12M -71.14M -4.83B -71.76M -500M -194M -2.46B -189M -185M -8.01B
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
26-09-23 ₩8,180.00 +12.21% 1,188,856
26-09-22 ₩7,290.00 +7.68% 808,005
26-09-21 ₩6,770.00 -1.88% 82,408
26-09-18 ₩6,900.00 -1.43% 148,168
26-09-17 ₩7,000.00 +4.01% 437,733

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock